The following OncLive video interview with two leading renal cell carcinoma (RCC) experts, Dr Brian Rini, Cleveland Clinic Lerner College of Medicine, and Dr David McDermott, Harvard Cancer Center, summarises how the treatment and prognosis of metastatic RCC has changed over recent years, and looks forward to the advent of combination therapies in the future.

Watch the video by Onclive here